Free Trial

Uranium Royalty (UROY) Expected to Announce Quarterly Earnings on Thursday

Uranium Royalty logo with Energy background

Key Points

  • Uranium Royalty Corp. is set to announce its Q1 2026 earnings on September 11th, with expected losses of ($0.01) per share and revenues of $9.493 million.
  • Previously, the company reported earnings of ($0.01) per share and revenues of $3.30 million for the last quarter, significantly below analysts' expectations.
  • Institutional investors have increased their stakes in Uranium Royalty, with Corient Private Wealth and Thompson Davis acquiring new shares, while Goldman Sachs enhanced its holdings by 25.4%.
  • MarketBeat previews top five stocks to own in November.

Uranium Royalty (NASDAQ:UROY - Get Free Report) is expected to post its Q1 2026 results before the market opens on Thursday, September 11th. Analysts expect Uranium Royalty to post earnings of ($0.01) per share and revenue of $9.4930 million for the quarter. Parties may visit the the company's upcoming Q1 2026 earningresults page for the latest details on the call scheduled for Monday, September 15, 2025 at 4:00 PM ET.

Uranium Royalty (NASDAQ:UROY - Get Free Report) last released its quarterly earnings results on Wednesday, July 16th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). The firm had revenue of $3.30 million for the quarter, compared to analysts' expectations of $9.49 million. On average, analysts expect Uranium Royalty to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Uranium Royalty Trading Down 3.5%

Shares of UROY stock traded down $0.12 during mid-day trading on Monday, reaching $3.16. The stock had a trading volume of 336,805 shares, compared to its average volume of 3,044,627. The business's fifty day moving average is $2.74 and its 200-day moving average is $2.24. The firm has a market cap of $421.63 million, a price-to-earnings ratio of -105.53 and a beta of 1.32. Uranium Royalty has a 1-year low of $1.43 and a 1-year high of $3.34.

Institutional Trading of Uranium Royalty

A number of hedge funds and other institutional investors have recently bought and sold shares of UROY. Vident Advisory LLC raised its holdings in Uranium Royalty by 47.1% during the second quarter. Vident Advisory LLC now owns 1,480,151 shares of the company's stock worth $3,700,000 after purchasing an additional 474,030 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of Uranium Royalty by 25.4% in the first quarter. Goldman Sachs Group Inc. now owns 104,243 shares of the company's stock valued at $183,000 after buying an additional 21,118 shares during the last quarter. Thompson Davis & CO. Inc. purchased a new stake in Uranium Royalty in the second quarter valued at approximately $33,000. Finally, Corient Private Wealth LLC purchased a new position in Uranium Royalty during the second quarter worth approximately $29,000. 24.19% of the stock is currently owned by institutional investors and hedge funds.

Uranium Royalty Company Profile

(Get Free Report)

Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. The company has royalty interests in the McArthur River, Cigar Lake / Waterbury Lake, Roughrider, Russell Lake, Russell Lake south, and Dawn Lake projects in Saskatchewan, Canada; Anderson and San Rafael projects in Arizona; Lance and Reno Creek projects in Wyoming; Church Rock and Roca Honda projects in New Mexico; Dewey-Burdock project in South Dakota; Slick Rock project in Colorado; Langer Heinrich project in Namibia; and Michelin project in Newfoundland and Labrador, Canada; Energy Queen and Whirlwind project in Utah; and Workman Creek projects in Arizona.

Featured Articles

Earnings History for Uranium Royalty (NASDAQ:UROY)

Should You Invest $1,000 in Uranium Royalty Right Now?

Before you consider Uranium Royalty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uranium Royalty wasn't on the list.

While Uranium Royalty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Dip: 3 Healthcare Stocks Ready to Recover
3 Options Myths Costing You Money (Do This Instead)
The Best & Worst Stocks in the Market Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines